You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mosunetuzumab

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • Mosunetuzumab
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023

Refractory B-cell Acute Lymphoblastic Leukemia Trial in Houston (Mosunetuzumab)

Not yet recruiting
  • Refractory B-cell Acute Lymphoblastic Leukemia
  • Mosunetuzumab
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2023

Lymphoma, Follicular Trial (Mosunetuzumab)

Not yet recruiting
  • Lymphoma, Follicular
  • Mosunetuzumab
  • (no location specified)
May 8, 2023

DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma, Transformed Indolent B-Cell Non-Hodgkin Lymphoma to DLBCL Trial

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 5, 2023

Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

Recruiting
  • Lymphoma, Follicular
  • Follicular Lymphoma
  • Mosunetuzumab
  • Polatuzumab vedotin
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

Recruiting
  • B Cell Lymphoma
  • +5 more
  • Mosunetuzumab
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Mosunetuzumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma Trial in New Haven, New Brunswick, Providence (Mosunetuzumab,

Recruiting
  • Follicular Lymphoma
  • +2 more
  • New Haven, Connecticut
  • +2 more
Jul 14, 2022

Follicular Lymphoma, Lymphoma Trial in United States (Mosunetuzumab)

Recruiting
  • Follicular Lymphoma
  • Lymphoma
  • Mosunetuzumab
  • Basking Ridge, New Jersey
  • +6 more
Nov 9, 2022

Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

Not yet recruiting
  • Refractory Non-Hodgkin Lymphoma
  • +2 more
  • Mosunetuzumab
  • +2 more
  • Miami, Florida
    University of Miami
Aug 3, 2022

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed B-Cell Lymphoma Trial in Saint Louis (Mosunetuzumab,

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Mosunetuzumab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 14, 2022

Large B-cell Lymphoma Trial in Philadelphia (mosunetuzumab, glofitamab, obinutuzumab)

Recruiting
  • Large B-cell Lymphoma
  • mosunetuzumab
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 21, 2022

Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab, Polatuzumab vedotin, Tocilizumab)

Recruiting
  • Non-Hodgkin Lymphoma
  • Mosunetuzumab
  • +5 more
  • Buenos Aires, Argentina
  • +18 more
Aug 10, 2022

B-cell Lymphoma Trial in Randwick, Clayton, Fitzroy (Glofitamab, Gemcitabine, Oxaliplatin)

Completed
  • B-cell Lymphoma
  • Randwick, New South Wales, Australia
  • +2 more
Nov 23, 2021

DLBCL, Grade 3b Follicular Lymphoma, Primary Mediastinal (Thymic) Large B-Cell Lymphoma Trial (biological, procedure, drug,

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • +6 more
  • Axicabtagene Ciloleucel
  • +10 more
  • (no location specified)
Jan 13, 2023

Relapsed or Refractory Follicular Lymphoma Trial in Worldwide (Mosunetuzumab, Lenalidomide, Rituximab)

Recruiting
  • Relapsed or Refractory Follicular Lymphoma
  • Mosunetuzumab
  • +3 more
  • Duarte, California
  • +108 more
Jul 26, 2022